India rolled-out the COVID vaccination for children aged between 15 and 18 years on January 3 amid a surge in the COVID-19 cases in various parts...
Covid booster dose: The findings compiled in a report by the UK Health Security Agency (UKSHA) show significantly higher protection provided by third dose of COVID-19...
India began vaccinating 15 to 18 year olds from January 3 using indigenously-developed Bharat Biotech’s Covaxin
Covid panel chief Dr NK Arora explained the possible benefits of vaccinating children in the 15-18 age group, saying these people may get infected at schools...
The study, published in the journal Nature on Thursday (December 23), also highlights the need for new vaccines and treatments that anticipate how the SARS-CoV-2 virus...
According to Dr Randeep Guleria, Director, AIIMS Delhi, current vaccines are effective but with new variants, they will decrease on immunity, however vaccines can be tweaked
According to WHO, while the effectiveness of vaccines against severe Covid has fallen slightly, these are still important and contribute in preventing deaths
Vineeta Bal, immunologist recommends fully vaccinating all those eligible in the country first, before going for booster doses, as still a large proportion of India's population...
Omicron variant's spike protein contained mutations known to increase the transmissibility of the virus, says Sarah Gilbert, one of the co-creators of the Oxford-AstraZeneca vaccine
The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six...
In a meeting, it was emphasised that the pace of COVID vaccination should be enhanced for maximum coverage, informed Delhi Lieutenant Governor Anil Baijal through a...
Union Minister for Science and Technology Jitendra Singh on Saturday (November 27) launched the first-of-its-kind drone driven aerial delivery facility to transport COVID vaccines as well...
A new study suggest that a third dose of Covid vaccine can reduce risk of Covid-related hospitalisation by 93 per cent
This is the first survey to be done after Delhi was hit by a brutal second wave of the Covid pandemic in April and May
There have been reports of rare neurological complications associated with SARS-CoV-2 infection and Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccines
